BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hernández-Conde M, Llop E, Fernández Carrillo C, Tormo B, Abad J, Rodriguez L, Perelló C, López Gomez M, Martínez-Porras JL, Fernández Puga N, Trapero-Marugan M, Fraga E, Ferre Aracil C, Calleja Panero JL. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(42): 6658-6668 [PMID: 33268953 DOI: 10.3748/wjg.v26.i42.6658]
URL: https://www.wjgnet.com/1007-9327/full/v26/i42/6658.htm
Number Citing Articles
Yuping Ding, Quanjun Deng, Mei Yang, Haiyan Niu, Zuoyu Wang, Shihai Xia. Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and TreatmentDiabetes, Metabolic Syndrome and Obesity 2023; : 3303 doi: 10.2147/DMSO.S431251
Giada Sebastiani, Nathalie Paisible, Cecilia Costiniuk, Joseph Cox, Dana Kablawi, Marina B. Klein, Nadine Kronfli, Jean-Pierre Routy, Julian Falutz, Bertrand Lebouché, Giovanni Guaraldi. The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot StudyDiagnostics 2022; 12(11): 2590 doi: 10.3390/diagnostics12112590
Yongshuai Liu, Huijun Chang, Yunqing Zeng, Jinhou Li, Yueyue Li, Yong Chen, Tao Zhou, Yanjing Gao. Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort studyLipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-023-01996-9
Vasilios Kotsis, Fernando Martinez, Christina Trakatelli, Josep Redon. Impact of Obesity in Kidney DiseasesNutrients 2021; 13(12): 4482 doi: 10.3390/nu13124482
Deng-Hua He, Yong-Zhan Zhang, Liang Xu, Jia-Jia Pei, Ying Zhang, Zhong-Fang Yan. Relationship between metabolic associated fatty liver disease and body fat ratio, visceral fat area, and resting metabolic rate estimated by bioelectrical impedance analysisWorld Chinese Journal of Digestology 2023; 31(2): 56 doi: 10.11569/wcjd.v31.i2.56
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
Jian Yang, Chuan Wang Li, Jing Ru Zhang, Honglin Qiu, Xiu Li Guo, Wei Wang. Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes MellitusDiabetes, Metabolic Syndrome and Obesity 2023; : 1953 doi: 10.2147/DMSO.S415477
M. Hernández-Conde, J.L. Calleja. La enfermedad hepática metabólica: una nueva pandemia prevenibleRevista de Gastroenterología de México 2023; 88(3): 197 doi: 10.1016/j.rgmx.2022.04.002
M. Hernández-Conde, J.L. Calleja. Metabolic liver disease: A new preventable pandemicRevista de Gastroenterología de México (English Edition) 2023; 88(3): 197 doi: 10.1016/j.rgmxen.2022.04.003
Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Ou-Yang Huang, Rafael S. Rios, Kenneth I. Zheng, Sui-Dan Chen, Hong-Lei Ma, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Translational Hepatology 2022; 10(3): 439 doi: 10.14218/JCTH.2021.00286
Yasir Mohammed Khayyat. Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi ArabiaWorld Journal of Hepatology 2021; 13(12): 2150-2160 doi: 10.4254/wjh.v13.i12.2150
Ker Ming Seaw, Christiani Jeyakumar Henry, Xinyan Bi. Relationship between Non-Alcoholic Fatty Liver Disease and Visceral Fat Measured by Imaging-Based Body Composition Analysis: A Systematic ReviewLivers 2023; 3(3): 463 doi: 10.3390/livers3030033
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic InterplayLife 2024; 14(2): 272 doi: 10.3390/life14020272